US Stock MarketDetailed Quotes

NGNE Neurogene

Watchlist
  • 43.720
  • +1.460+3.45%
Trading Jul 22 15:31 ET
567.50MMarket Cap-15437P/E (TTM)

Neurogene Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neurogene Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-1.00

+87.97%
Analyst Rating

Strong Buy

Jul 22, 2024

Neurogene Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--------

Unlock Free Earnings Estimates

Neurogene Earnings Reports

  • Neurogene | 10-Q: Quarterly report

    May 10 16:21 ET

  • Neurogene | 10-K: Annual report

    Mar 18 16:06 ET

  • Neoleukin Therapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 08:16 ET

  • Neoleukin Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 16:13 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 22, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg